Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cell Stem Cell | journal | 14.969 Q1 | 305 | 181 | 549 | 5383 | 8757 | 455 | 14.74 | 29.74 | 34.31 | |
2 | Pharmacological Reviews | journal | 10.386 Q1 | 254 | 33 | 59 | 10674 | 1354 | 59 | 21.41 | 323.45 | 20.91 | |
3 | Stem Cells | journal | 4.734 Q1 | 253 | 208 | 885 | 10495 | 8198 | 841 | 8.54 | 50.46 | 40.54 | |
4 | Molecular Therapy | journal | 3.460 Q1 | 209 | 275 | 790 | 10988 | 5469 | 693 | 6.88 | 39.96 | 37.93 | |
5 | ACS Chemical Biology | journal | 3.422 Q1 | 135 | 163 | 337 | 6394 | 1878 | 296 | 5.90 | 39.23 | 29.77 | |
6 | Medicinal Research Reviews | journal | 3.242 Q1 | 150 | 24 | 83 | 4735 | 864 | 81 | 9.73 | 197.29 | 32.35 | |
7 | Cell Chemical Biology | journal | 2.882 Q1 | 206 | 206 | 489 | 7558 | 2320 | 443 | 4.52 | 36.69 | 32.34 | |
8 | Molecular Pharmacology | journal | 2.518 Q1 | 210 | 223 | 854 | 8969 | 4551 | 853 | 5.38 | 40.22 | 34.83 | |
9 | Molecular Pharmaceutics | journal | 2.351 Q1 | 156 | 248 | 520 | 12378 | 3267 | 505 | 5.49 | 49.91 | 36.09 | |
10 | Journal of Medicinal Chemistry | journal | 2.252 Q1 | 301 | 703 | 2440 | 33350 | 14323 | 2436 | 5.63 | 47.44 | 35.26 | |
11 | NeuroMolecular Medicine | journal | 2.196 Q1 | 82 | 41 | 103 | 2117 | 617 | 103 | 5.84 | 51.63 | 34.29 | |
12 | Molecular Medicine | journal | 2.049 Q1 | 133 | 152 | 197 | 6863 | 1118 | 190 | 4.18 | 45.15 | 36.95 | |
13 | Nanomedicine: Nanotechnology, Biology, and Medicine | journal | 2.013 Q1 | 151 | 112 | 191 | 4788 | 1454 | 186 | 7.49 | 42.75 | 34.18 | |
14 | Journal of Pharmacology and Experimental Therapeutics | journal | 1.787 Q1 | 244 | 406 | 1385 | 15944 | 6246 | 1375 | 4.18 | 39.27 | 34.75 | |
15 | Human Gene Therapy | journal | 1.766 Q1 | 159 | 187 | 401 | 7011 | 1737 | 367 | 4.29 | 37.49 | 35.54 | |
16 | Pharmaceutical Research | journal | 1.678 Q1 | 229 | 277 | 809 | 13395 | 4037 | 766 | 4.68 | 48.36 | 34.66 | |
17 | Journal of Experimental Zoology Part B: Molecular and Developmental Evolution | journal | 1.539 Q1 | 70 | 50 | 184 | 3116 | 461 | 179 | 2.45 | 62.32 | 38.54 | |
18 | American Journal of Translational Research (discontinued) | journal | 1.451 Q2 | 80 | 44 | 77 | 2453 | 274 | 73 | 3.56 | 55.75 | 31.02 | |
19 | Journal of Natural Products | journal | 1.384 Q2 | 161 | 397 | 1240 | 12192 | 4226 | 1217 | 3.47 | 30.71 | 35.95 | |
20 | Pharmacogenetics and Genomics | journal | 1.315 Q2 | 152 | 112 | 332 | 4614 | 1395 | 327 | 3.96 | 41.20 | 38.26 | |
21 | BioFactors | journal | 1.307 Q2 | 113 | 60 | 221 | 3724 | 854 | 213 | 5.36 | 62.07 | 42.58 | |
22 | Molecular Interventions | journal | 1.295 Q2 | 78 | 20 | 114 | 839 | 345 | 106 | 2.29 | 41.95 | 40.00 | |
23 | Cancer Biology and Therapy | journal | 1.263 Q2 | 130 | 257 | 1029 | 11395 | 2566 | 759 | 2.26 | 44.34 | 39.29 | |
24 | Molecular Imaging | journal | 1.107 Q2 | 66 | 48 | 93 | 1983 | 321 | 91 | 3.25 | 41.31 | 32.20 | |
25 | Blood Cells, Molecules, and Diseases | journal | 1.095 Q2 | 98 | 103 | 350 | 3194 | 884 | 299 | 2.27 | 31.01 | 48.45 | |
26 | Nucleic Acid Therapeutics | journal | 1.071 Q2 | 77 | 49 | 110 | 1963 | 336 | 110 | 2.97 | 40.06 | 39.11 | |
27 | Nuclear Medicine and Biology | journal | 1.042 Q2 | 98 | 135 | 337 | 4079 | 1036 | 330 | 3.27 | 30.21 | 30.10 | |
28 | Journal of Biomolecular Screening | journal | 0.987 Q2 | 86 | 129 | 344 | 3576 | 820 | 341 | 2.25 | 27.72 | 34.12 | |
29 | Journal of Cardiovascular Translational Research | journal | 0.982 Q2 | 60 | 87 | 214 | 4822 | 490 | 198 | 2.99 | 55.43 | 28.86 | |
30 | OMICS A Journal of Integrative Biology | journal | 0.956 Q2 | 69 | 107 | 140 | 5020 | 367 | 132 | 2.73 | 46.92 | 41.13 | |
31 | Journal of Gene Medicine | journal | 0.891 Q2 | 100 | 64 | 331 | 2607 | 944 | 322 | 2.83 | 40.73 | 35.51 | |
32 | Viral Immunology | journal | 0.884 Q3 | 70 | 60 | 188 | 2017 | 358 | 170 | 1.86 | 33.62 | 43.27 | |
33 | Vascular Pharmacology | journal | 0.816 Q3 | 108 | 42 | 200 | 2140 | 495 | 196 | 2.25 | 50.95 | 44.10 | |
34 | Assay and Drug Development Technologies | journal | 0.656 Q3 | 65 | 100 | 283 | 2048 | 255 | 150 | 0.99 | 20.48 | 35.28 | |
35 | Biotechnology and Applied Biochemistry | journal | 0.616 Q3 | 81 | 57 | 220 | 2460 | 429 | 220 | 2.01 | 43.16 | 42.28 | |
36 | Chemistry and Biodiversity | journal | 0.597 Q3 | 83 | 181 | 627 | 7785 | 1322 | 620 | 1.97 | 43.01 | 35.67 | |
37 | MCB Molecular and Cellular Biomechanics | journal | 0.551 Q3 | 31 | 18 | 56 | 629 | 79 | 56 | 1.06 | 34.94 | 32.65 | |
38 | Journal of Biochemical and Molecular Toxicology | journal | 0.516 Q3 | 69 | 48 | 143 | 1818 | 238 | 140 | 1.48 | 37.88 | 45.32 | |
39 | Probiotics and Antimicrobial Proteins | journal | 0.419 Q3 | 52 | 25 | 36 | 1178 | 50 | 35 | 1.39 | 47.12 | 29.27 | |
40 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.369 Q3 | 53 | 118 | 315 | 2942 | 357 | 314 | 0.97 | 24.93 | 35.14 | |
41 | Advances in Pharmacological Sciences | journal | 0.270 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
42 | Journal of Stem Cells | journal | 0.265 Q4 | 21 | 32 | 44 | 1894 | 25 | 43 | 0.92 | 59.19 | 44.19 | |
43 | Methods in molecular medicine | book series | 0.261 Q4 | 59 | 0 | 67 | 0 | 41 | 66 | 0.00 | 0.00 | 0.00 | |
44 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.124 Q4 | 16 | 57 | 162 | 2128 | 32 | 162 | 0.29 | 37.33 | 56.18 | |
45 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.118 Q4 | 29 | 11 | 18 | 591 | 7 | 0 | 0.40 | 53.73 | 0.00 | |
46 | 2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009 | conference and proceedings | 0.114 | 6 | 0 | 70 | 0 | 11 | 69 | 0.16 | 0.00 | 0.00 | |
47 | Methods in Pharmacology and Toxicology | book series | 0.112 Q4 | 14 | 0 | 22 | 0 | 4 | 21 | 0.00 | 0.00 | 0.00 | |
48 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.105 Q4 | 14 | 37 | 22 | 1362 | 5 | 21 | 0.23 | 36.81 | 37.27 | |
49 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.103 Q4 | 40 | 0 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
50 | 2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010 | conference and proceedings | 0.100 | 5 | 0 | 53 | 0 | 3 | 50 | 0.06 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®